<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01738971</url>
  </required_header>
  <id_info>
    <org_study_id>Protocol ECfe03</org_study_id>
    <secondary_id>182.</secondary_id>
    <nct_id>NCT01738971</nct_id>
  </id_info>
  <brief_title>Initiating Contraception After Emergency Contraception From Pharmacy</brief_title>
  <official_title>Pharmacy Based Interventions for Initiating Effective Contraception Following the Use of Emergency Contraception : a Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Edinburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NHS Lothian</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>London School of Hygiene and Tropical Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Edinburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pharmacists do not provide immediate contraception to women after emergency contraception
      (EC); they can only give advice on local contraceptive services.

      The investigators wish to establish the following 2 pharmacy- based interventions in NHS
      Lothian, designed to increase uptake of effective contraception as soon as possible, after EC

        1. Pharmacists would provide one packet of progestogen-only pills, giving women one month
           to arrange an appointment with contraceptive services.

        2. Rapid access to a family planning clinic upon presentation of the empty EC packet. Women
           would be seen as a 'walk-in' and contraception provided.

      If feasible, these interventions could reduce unintended pregnancies.

      Participating pharmacies will be randomised to provide one of the interventions, or standard
      care (verbal/written advice on local contraceptive services).

      Women requesting EC from study pharmacies will be recruited by the research nurse/doctor to
      participate in the study that will involve them consenting to contact by telephone 6-8 weeks
      after EC by the researcher, to evaluate the interventions in terms of :

      (i) determine women's experiences/ views of the interventions and control. (ii) determine if
      women have commenced effective contraception and if not , reasons why.

      A subset of 12 women will also be invited for in-depth interview to collect more detailed
      qualitative data on their EC experience.

      The investigators also wish to (iii) explore pharmacists views on the interventions

      Data from this pilot will enable the investigators to determine whether a larger multisite
      study is feasible. The aims of a larger study being to determine if either of the two
      interventions being tested result in an increased proportion of women using effective ongoing
      contraception compared to the control.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators propose to test 2 pharmacy based interventions to increase uptake of
      effective contraception after EC:

        1. Pharmacists would provide one packet of progestogen-only pills to women, so that they
           would have 28 days to arrange an appointment with contraceptive services to get a supply
           of ongoing contraception.

        2. Rapid access to a family planning clinic upon presentation of their empty(used) packet
           of EC. Women would be seen as a 'walk-in' (without appointment) and ongoing
           contraception discussed and provided.

      These interventions would be compared with the status quo, i.e. pharmacists give verbal
      advice and written information on local contraceptive services where ongoing contraception
      can be accessed.

      The interventions that we are testing are low cost i.e one packet of progestogen-only pills
      (£3 for most costly brand) plus additional consultation time with the pharmacist (estimated
      20 mins@ £1 per minute), versus the staff consultation time in a family planning clinic. In
      the family planning clinic, women would be seen as a 'walk-in' and so this may not add costs,
      since staff are already present.These interventions could, if shown to be effective, offer
      huge costs savings to the NHS, by reducing the costs of unintended pregnancies (abortion,
      miscarriage, birth).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Self-reported Uptake of Effective Ongoing Contraception (Not Condoms)</measure>
    <time_frame>6-8 weeks after EC</time_frame>
    <description>Outcome measure identified when participants conducted for agreed telephone interview 6-8 weeks following recruitment to study. Participants asked via telephone what method of contraception, if any, there were currently using.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pharmacy Recruitment Rates</measure>
    <time_frame>8 months</time_frame>
    <description>Proportion of participants that pharmacists were successful in recruiting during the specified 8 month recruitment time period. Initial target set to recruit 60 participants to each arm/group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Completeness (Quality) of Data Recorded by Pharmacists (Numbers of Women Attending for EC,Demographics of All Attendees- Age, Ethnicity Etc)</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of Women Who Agree to Participate Who Can be Successfully Contacted</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Qualitative Outcomes : Women's Views on Different Measures to Determine Validity of Self-reported Data on Contraceptive Use , Determined by in Depth Interviews.</measure>
    <time_frame>8 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Qualitative Outcomes : Pharmacist's Views on Interventions and Any Study Difficulties</measure>
    <time_frame>12 months</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">168</enrollment>
  <condition>Contraceptive Use After Emergency Contraception</condition>
  <arm_group>
    <arm_group_label>control (standard care)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard verbal and written advice on contraception from pharmacy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>rapid access</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rapid access to family planning service</description>
  </arm_group>
  <arm_group>
    <arm_group_label>progestogen only pill</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>one month progestogen only pill</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>rapid access</intervention_name>
    <description>Provision of box which the participant can take to local family planning clinic (contraceptive service) allowing rapid access (i.e. will be seen by a health professional for a consultation regarding contraception there and then).</description>
    <arm_group_label>rapid access</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>one month progestogen only pill</intervention_name>
    <description>Provision of 1 month supply of a progestogen only pill (levonorgestrel 35mcg - Norgeston, Bayer, UK)</description>
    <arm_group_label>progestogen only pill</arm_group_label>
    <other_name>Norgeston (Bayer, UK)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;= 16 yrs

          -  requesting emergency contraception

          -  eligible for emergency contraception

          -  written , informed consent

        Exclusion Criteria:

          -  age &lt; 16 yrs

          -  not able to give written , informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sharon T Cameron, MBChB</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Edinburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chalmers sexual and reproductive health service</name>
      <address>
        <city>Edinburgh</city>
        <state>Lothian</state>
        <zip>EH39ES</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2012</study_first_submitted>
  <study_first_submitted_qc>November 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2012</study_first_posted>
  <results_first_submitted>June 23, 2014</results_first_submitted>
  <results_first_submitted_qc>August 1, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 18, 2014</results_first_posted>
  <last_update_submitted>August 1, 2014</last_update_submitted>
  <last_update_submitted_qc>August 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 18, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>emergency contraception</keyword>
  <keyword>community pharmacy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Progestins</mesh_term>
    <mesh_term>Levonorgestrel</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment from end April 2012 - end December 2012 (8 month period). Recruitment of participants by community pharmacists within 11 community pharmacies in Edinburgh.
All participating pharmacists trained by the research team prior to commencing recruitment of participants.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Control (Standard Care)</title>
          <description>standard verbal and written advice on contraception from pharmacy</description>
        </group>
        <group group_id="P2">
          <title>Rapid Access</title>
          <description>rapid access to family planning service
rapid access to contraceptive service</description>
        </group>
        <group group_id="P3">
          <title>Progestogen Only Pill</title>
          <description>one month progestogen only pill
one month progestogen only pill</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="54">54 participants recruited to this arm</participants>
                <participants group_id="P2" count="58">58 participants recruited to this arm</participants>
                <participants group_id="P3" count="56">56 participants recruited to this arm</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="35">35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.</participants>
                <participants group_id="P2" count="28">28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.</participants>
                <participants group_id="P3" count="39">39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="30"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="30"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Baseline analysis conducted on all participants successfully contacted for telephone follow-up at 6-8weeks post enrollment to study. no baseline analysis possible on those recruited in pharmacy but lost to follow-up.</population>
      <group_list>
        <group group_id="B1">
          <title>Control (Standard Care)</title>
          <description>standard verbal and written advice on contraception from pharmacy</description>
        </group>
        <group group_id="B2">
          <title>Rapid Access</title>
          <description>rapid access to family planning service
rapid access to contraceptive service</description>
        </group>
        <group group_id="B3">
          <title>Progestogen Only Pill</title>
          <description>one month progestogen only pill
one month progestogen only pill</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="35"/>
            <count group_id="B2" value="28"/>
            <count group_id="B3" value="39"/>
            <count group_id="B4" value="102"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23" spread="4.5"/>
                    <measurement group_id="B2" value="25" spread="5.6"/>
                    <measurement group_id="B3" value="22" spread="5.2"/>
                    <measurement group_id="B4" value="23" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="39"/>
                    <measurement group_id="B4" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="39"/>
                    <measurement group_id="B4" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Contraception use at time of enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Condoms</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other method</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Self-reported Uptake of Effective Ongoing Contraception (Not Condoms)</title>
        <description>Outcome measure identified when participants conducted for agreed telephone interview 6-8 weeks following recruitment to study. Participants asked via telephone what method of contraception, if any, there were currently using.</description>
        <time_frame>6-8 weeks after EC</time_frame>
        <population>A small number of participants were identified who had been recruited to the study although were already using an effective method of contraception (i.e. using a contraceptive pill but had forgot to take), and continued to use the same method at follow-up. These participants were excluded from analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Control (Standard Care)</title>
            <description>standard verbal and written advice on contraception from pharmacy</description>
          </group>
          <group group_id="O2">
            <title>Rapid Access</title>
            <description>rapid access to family planning service
rapid access to contraceptive service</description>
          </group>
          <group group_id="O3">
            <title>Progestogen Only Pill</title>
            <description>one month progestogen only pill
one month progestogen only pill</description>
          </group>
        </group_list>
        <measure>
          <title>Self-reported Uptake of Effective Ongoing Contraception (Not Condoms)</title>
          <description>Outcome measure identified when participants conducted for agreed telephone interview 6-8 weeks following recruitment to study. Participants asked via telephone what method of contraception, if any, there were currently using.</description>
          <population>A small number of participants were identified who had been recruited to the study although were already using an effective method of contraception (i.e. using a contraceptive pill but had forgot to take), and continued to use the same method at follow-up. These participants were excluded from analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Effective contraception</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Long acting contraception</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No contraception / barrier method</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Cluster randomised study design - statisitical analysis takes this into account. Analaysis was conducted at a cluster level and the proportions in each cluster using effective contraception were compared between groups by 2-sample t tests, weighted by the different number of patients in each cluster.
Comparison of number of women using effective contraception at 6-8 weeks in progestogen only pill group compared to control.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>t-test, 2 sided</method>
            <method_desc>see above description of analysis taking into account cluster randomisation</method_desc>
            <param_type>relative probability</param_type>
            <param_value>3.13</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.90</ci_lower_limit>
            <ci_upper_limit>5.13</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Cluster randomised study design - statisitical analysis takes this into account. Analaysis was conducted at a cluster level and the proportions in each cluster using effective contraception were compared between groups by 2-sample t tests, weighted by the different number of patients in each cluster.
Comparison of number of women using effective contraception at 6-8 weeks in rapid access group compared to control.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.006</p_value>
            <p_value_desc>see above comments regarding analysis taking cluster randomised account into consideration</p_value_desc>
            <method>t-test, 2 sided</method>
            <param_type>relative probability</param_type>
            <param_value>2.57</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.55</ci_lower_limit>
            <ci_upper_limit>4.27</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pharmacy Recruitment Rates</title>
        <description>Proportion of participants that pharmacists were successful in recruiting during the specified 8 month recruitment time period. Initial target set to recruit 60 participants to each arm/group.</description>
        <time_frame>8 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control (Standard Care)</title>
            <description>standard verbal and written advice on contraception from pharmacy</description>
          </group>
          <group group_id="O2">
            <title>Rapid Access</title>
            <description>rapid access to family planning service
rapid access to contraceptive service</description>
          </group>
          <group group_id="O3">
            <title>Progestogen Only Pill</title>
            <description>one month progestogen only pill
one month progestogen only pill</description>
          </group>
        </group_list>
        <measure>
          <title>Pharmacy Recruitment Rates</title>
          <description>Proportion of participants that pharmacists were successful in recruiting during the specified 8 month recruitment time period. Initial target set to recruit 60 participants to each arm/group.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Recruited</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54"/>
                    <measurement group_id="O2" value="58"/>
                    <measurement group_id="O3" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not recruited from target figure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Completeness (Quality) of Data Recorded by Pharmacists (Numbers of Women Attending for EC,Demographics of All Attendees- Age, Ethnicity Etc)</title>
        <time_frame>8 months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Proportion of Women Who Agree to Participate Who Can be Successfully Contacted</title>
        <time_frame>8 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control (Standard Care)</title>
            <description>standard verbal and written advice on contraception from pharmacy</description>
          </group>
          <group group_id="O2">
            <title>Rapid Access</title>
            <description>rapid access to family planning service
rapid access to contraceptive service</description>
          </group>
          <group group_id="O3">
            <title>Progestogen Only Pill</title>
            <description>one month progestogen only pill
one month progestogen only pill</description>
          </group>
        </group_list>
        <measure>
          <title>Proportion of Women Who Agree to Participate Who Can be Successfully Contacted</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="58"/>
                <count group_id="O3" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Women successfully contacted for follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                    <measurement group_id="O2" value="28"/>
                    <measurement group_id="O3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not contacted / lost to follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Qualitative Outcomes : Women's Views on Different Measures to Determine Validity of Self-reported Data on Contraceptive Use , Determined by in Depth Interviews.</title>
        <time_frame>8 months</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Qualitative Outcomes : Pharmacist's Views on Interventions and Any Study Difficulties</title>
        <time_frame>12 months</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>14 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Control (Standard Care)</title>
          <description>standard verbal and written advice on contraception from pharmacy</description>
        </group>
        <group group_id="E2">
          <title>Rapid Access</title>
          <description>rapid access to family planning service
rapid access to contraceptive service</description>
        </group>
        <group group_id="E3">
          <title>Progestogen Only Pill</title>
          <description>one month progestogen only pill
one month progestogen only pill</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="56"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="56"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Loss to follow-up relatively high. Self-reporting of primary outcome measure (contraceptive method at time of follow-up). Would have been preferable to be able to validate this.
Pharmacists unable to record demographic data of those not recruited.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr Lucy Michie</name_or_title>
      <organization>University of Edinburgh</organization>
      <phone>0131 5361542</phone>
      <email>michieluc@yahoo.co.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

